TB-402
TB-402, a human IgG4 anticoagulant monoclonal antibody, is a partial Factor VIII inhibitor. TB-402 has a prolonged antithrombotic effect. TB-402 can be used for the prevention of venous thromboembolism (VTE) after total knee replacement (TKR) [1].
Product Specifications
UNSPSC
12352203
Target
Factor VIII
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
References & Citations
[1]Verhamme P, et al. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J Thromb Haemost. 2011 Apr;9 (4) :664-71.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-[[1- (Methylamino) -2-nitroethenyl]amino]-ethanethiol](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
IM183181-01 2 g
2-[[1- (Methylamino) -2-nitroethenyl]amino]-ethanethiol
Sign In for Pricing
View Details IM183181-02 5 g
2-[[1- (Methylamino) -2-nitroethenyl]amino]-ethanethiol
Sign In for Pricing
View Details IM183181-03 10 g
2-[[1- (Methylamino) -2-nitroethenyl]amino]-ethanethiol
Sign In for Pricing
View Details 
